GLYCOVAX PHARMA
Glycovax Pharma focuses on developing nano-medicines to treat cancers and other diseases.
GLYCOVAX PHARMA
Industry:
Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.glycovax.com
Total Employee:
1+
Status:
Active
Contact:
+1 855-579-3115
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Alliance Health Networks
Company currently undergoing official rebranding- stay tuned for details
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Mycovia Pharmaceuticals
Mycovia offers passionate about developing breakthrough therapies in women’s health and dermatology.
Wellcome Leap
Wellcome Leap focuses on discovery and innovation to improve human health.
Current Employees Featured
Official Site Inspections
http://www.glycovax.com Semrush global rank: 6.13 M Semrush visits lastest month: 1.32 K
- Host name: e112c3c9.panelvps.net
- IP address: 184.107.95.61
- Location: Montreal Canada
- Latitude: 45.4579
- Longitude: -73.5493
- Timezone: America/Toronto
- Postal: H3E
More informations about "Glycovax Pharma"
Glycovax Pharma - Crunchbase Company Profile & Funding
Organization. Glycovax Pharma . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Glycovax Pharma focuses on developing nano …See details»
Glycovax Pharma - LinkedIn
Glycovax Pharma | 658 followers on LinkedIn. Saving millions of lives by using the power of advanced medical nanotechnology. Changing the world of medicine by creating tomorrow’s …See details»
PHARMA GLYCOVAX INC. - canadacompanyregistry.com
PHARMA GLYCOVAX INC. / GLYCOVAX PHARMA INC. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 424, rue Guy, suite 202 Montréal QC …See details»
Glycovax Pharma will know in three months if its …
Apr 30, 2020 Glycovax Pharma scientific director and vice-president for research Dr. René Roy is confident the company is on track to finding a …See details»
AND INGENUITY OF ITS CLIENTS - ROBIC
Research. Since Glycovax Pharma is considered an essential service, Dany Valiquette is proud to say: “ The whole team is working very hard at Glycovax Pharma and is focused on one thing: …See details»
Glycovax Pharma Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Glycovax Pharma Inc. of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
ROBIC APPLAUDS THE AMAZING STORY OF GLYCOVAX!
May 19, 2020 Since Glycovax Pharma is considered an essential service, Dany Valiquette is proud to say: “The whole team is working very hard at Glycovax Pharma and is focused on …See details»
Glycovax Pharma develops a vaccine against COVID-19
Glycovax Pharma develops a vaccine against COVID-19 A semi-synthetic vaccine in the preclinical phase Montréal, Canada, April 21, 2020 - Glycovax Pharma, a biopharmaceutical …See details»
CQM researcher Serge Mignani nominated VP of Glycovax Pharma
The development of complementary diagnostic tests for personalized medicine is also in the aims of Glycovax Pharma. Professor Serge Mignani was, for more than 40 years, researcher in one …See details»
GlycoVaxyn AG | ETH Zurich - ETH Zürich
GlycoVaxyn utilized its biological conjugation platform to develop next-generation bioconjugate vaccines against bacterial infections. GlycoVaxyn and GSK launched a research collaboration …See details»
Faster future vaccine design | Research and Innovation
GLYCOVAX brings together eight research organisations and two industrial partners to support 14 early-stage researchers in helping to develop a novel process for producing glycoconjugate …See details»
Two INRS researchers involved in the process of creating a vaccine
Jun 18, 2020 Professors Nicolas Doucet and Yves St-Pierre of the Institut National de la Recherche Scientifique (INRS) are contributing their expertise in structural and cell biology to …See details»
Santé | Développement d’un vaccin: une véritable course contre la ...
May 19, 2020 Il souligne au passage que Glycovax espère obtenir un financement de 50 millions de dollars à même l’enveloppe de 1,3 milliard prévue à cette fin par le gouvernement Trudeau …See details»
INRS researchers involved in work to create a COVID-19 vaccine
Jun 23, 2020 Glycovax Pharma is one step ahead because antibody development is already ongoing,” says Professor Doucet. Even if antibodies are currently being synthesized, two key …See details»
Glycovax 002 - AdisInsight - Springer
Glycovax 002 a semi-synthetic glycoconjugate vaccine is being developed by Glycovax Pharma for the prevention of COVID-19 infections. Clinical development is ... If your organization has a …See details»
Glycovax-002 by Glycovax Pharma for Coronavirus Disease 2019 …
6 days ago Glycovax-002 overview. Glycovax-002 is under development for the prevention of coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 …See details»
La course aux remèdes: d’un traitement pour le cancer à celui pour …
Jun 20, 2020 La biopharmaceutique québécoise Glycovax, qui travaillait depuis quelques années sur le développement d’un vaccin novateur pour diverses formes de cancer, s’est …See details»
Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy …
Glycovax Pharma has developed a glycoconjugate vaccine candidate called Glycovax-002 to fight the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the origin of COVID …See details»
MimiVax and UI Pharmaceuticals Achieve Milestone in SurVaxM …
1 day ago SurVaxM is the first drug product to be produced in UI Pharmaceuticals new facility; UI Pharmaceuticals is looking forward to supporting the need for larger clinical and commercial …See details»
Un prototype de vaccin permettant de contrer la COVID-19 est ...
Apr 21, 2020 Cofondateur de Glycovax Pharma, le Dr Roy est professeur émérite de l’Université du Québec à Montréal (UQÀM) et professeur associé à l’Institut Armand Frappier de l’INRS. …See details»